Update 2022-08-032022-08-03
CLASSES
- Tirzépatide(Mounjaro) approuvé pour le traitement du DB2 par la FDA en mai 2022 au Canada à venir Résultats très impressionnants sur la baisse A1C et le poids. Voir le résumé du programme Surpass
- Ozempic® - Clinical Trials: SEMA 2.4 (STEP 2) + SUSTAIN FORTE *Semaglutide 2 mg and 2.4 mg are not yet available for purchase in Canada (coming soon)
Glucagon
- La présente a pour but de vous informer qu’Eli Lilly and Company a décidé de cesser la distribution de GLUCAGON (Glucagon pour injection, source ADNr) pour tous les marchés. Nous avons décidé d’arrêter la fabrication du GLUCAGON (Glucagon pour injection, source ADNr) et de notre trousse d’urgence de GLUCAGON à l’échelle mondiale en raison de la diminution de la demande et de nos efforts pour rationaliser nos processus de fabrication.
Nous comprenons qu’il est essentiel pour les personnes atteintes de diabète d’avoir un traitement par glucagon d’urgence à portée de main en cas d’hypoglycémie sévère. Notre produit de glucagon en vaporisateur nasal demeurera disponible au Canada pour le traitement de l’hypoglycémie sévère chez les personnes diabétiques traitées à l’insuline (âgées de 4 ans et plus), lorsqu’une altération de la conscience empêche la prise de glucides par voie orale.
Lilly avise les médecins et les autres fournisseurs de soins de santé des échéanciers de l'arrêt de la distribution, que vous trouverez ci-dessous, afin de leur laisser suffisamment de temps pour discuter d’autres options de traitement par le glucagon avec leurs patients qui utilisent actuellement le GLUCAGON de Lilly (Glucagon pour injection, source ADNr) et de les transférer vers d’autres formes de traitement.
Nous prévoyons que la dernière distribution de GLUCAGON (Glucagon pour injection, source ADNr) de Lilly aux distributeurs pharmaceutiques au Canada aura lieu vers juillet 2023. Bien qu’il s’agisse de la dernière date de distribution prévue, GLUCAGON peut être utilisé jusqu’à la date d’expiration indiquée sur le produit.
Lifestyle
- Nutrition - Coup d'oeil alimentation (DQ)
- Hypoglycemia - Symptômes et mesures à prendre (DQ)
- Hypoglycemia - Aide mémoire de poche (DQ)
- Mental Health - La dépression et le diabète (DQ)
- Mental Health - Le stress et le diabète (DQ)
- Sexuality - Diabète et sexualité féminine (DQ)
- Foot Care - Soins des pieds (DQ)
2022-05-25
Resources
- Exam Preparation - Insulin Matters Program from Sanofi
Drug and Renal Function
2022-04-17
CLASSES
- New indication for Jardiance® 10mg in Heart Failure with PRESERVED EJECTION FRACTION approved by Health Canada
- Jardiance® - New Monograph
- Jardiance® - New Clinical Trial: EMPEROR Preserved NEJM August 2021
2022-04-02
Ressources
- Ramadan - Calendar
2022-03-02
Insulin
- EntuzityTM - Now covered by the Quebec Health Insurance Board (RAMQ)
2022-02-03
Insulin
- Trurapi® - Now covered by the Quebec Health Insurance Board (RAMQ)
- Complete list of biosimilars and RAMQ instructions for transition by April 13. (Info RAMQ)
(see Continuing Education/Presentation Archives/Training on biosimilars tab for more information)
2022-02-02
Insulin
Treatment
- Baqsimi is Now Listed on the Régie de l'assurance maladie du Québec (RAMQ*). The cost of Baqsimi is covered under the general plan only for people receiving insulin. (Info RAMQ)
Also
Baqsimi is now reimbursed by all federal benefit programs, including the Non-Insured Health Benefits (NIHB) program, Veterans Affairs Canada (VAC) and Correctional Services Canada (CSC)
(see Resources/Education/Glucagon/Baqsimi tab for more information)
2021-12-18
CLASSES
- Forxiga® (Dapagliflozin) is now covered by the RAMQ: Code CV399 for the treatment of people with class II or III heart failure for adults with or without diabetes who present with left ventricular systolic dysfunction (with ejection fraction ≤ 40%) and who have been receiving an ACEI or ARB for at least 4 weeks in combination with a beta-blocker, unless there is a contraindication or intolerance.
2021-12-04
Continuing Education
2021-11-28
Drug and Renal Function
2021-11-08
CLASSES
- Jardiance® - New Health Canada Approval : Is indicated in adults with or without type 2 diabetes for the treatment of heart failure with reduced ejection fraction (Monograph).
2021-11-07
Insulins
- Trurapi® - New Clinical Trial: GEMELLI 1 Study
2021-11-03
Drug and Renal Function
2021-11-02
Drug and Renal Function
- Update of the Renal Function Adjustment Chart
CLASSES
- Januvia® - New Monograph
2021-10-21
Insulin - Tresiba®
2021-10-14
Diabetes Canada
- Blood Glucose Monitoring in Adults and Children with Diabetes: DC CPG Update 2021
2021-10-03
Insulins
- The summary table of insulins is now available here and is also available on the Insulins page (under the title)
2021-09-29
Lifestyle - Weight Management
- Obesity Canada - Canadian Adult Clinical Practice Guidelines
Continuing Education - Invitation
- The Management of Basal Insulins in the Context of Biosimilars, a Must!
Coverage - Infolettre RAMQ
2021-09-26
Insulin
- New Insulin (expected launch fall 2021) - Trurapi® (Biosimilar)
Lifestyle
- Add a New Tab - Weight Management (Content to Follow)
2021-09-22
Blood Glucose Monitoring
Diabetes Canada - Interactive Guide
2019-09-20
Drug and Renal Function
- Update of the Renal Function Adjustment Chart
2021-09-01
Add a New Tab - Continuing Education
- Events to Come (Content to Follow)
- Presentation Archives (Content to Follow)
2021-08-17
CLASSES - Forxiga - New product monograph
- New indication in Chronic Kidney Disease for FORXIGA.
Indicated to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular and renal death in adults with chronic kidney disease (CKD).
AND - FORXIGA is not recommended in patients with an eGFR less than 25 mL/min/1.73m2. On dialysis FORXIGA is contraindicated in patients on dialysis
2021-07-19
RAMQ Reimbursement
- As of July 7, 2021
-With the exceptions provided for in this regulation, as of July 7, 2021, patients who are covered by the public drug insurance plan for a reference biologic drug will have until April 12, 2022 inclusive to switch to the biosimilar drug (See Attached Infolettre RAMQ)
2021-07-14
Coverage
- RAMQ Codes update (PDF)
RAMQ Reimbursement
- As of July 7, 2021
- Maximum allowable quantity management for Trulicity, Victoza et Ozempic (See Attached Infolettre RAMQ)
2021-06-22
Diabetes Québec
- Update of the Product Guide 2021 (FR)
2021-06-16
Dexcom G6®
- Update of the Insertion site section in the CGM & FGM comparison
2021-06-12
Dexcom G6®
- Update of the cost section in the CGM & FGM comparison
Coverage
- RAMQ Codes update (PDF)
2021-05-26
Dexcom G6® - RAMQ coverage
- Dexcom G6® now with RAMQ coverage for DB1 age 2 and up starting May 27th under certain conditions (see the PDF document attached) - Eligibilty Criteria for RAMQ - RAMQ Payment Authorization Request Form
2021-05-14
Insulin
- Admelog® - Your guide to getting started
Diabetes Canada - Resources
2021-04-18
Educational Videos - Hypoglycemia
- What is Hypoglycemia?
- Preventing Hypoglycemia
- Nocturnal Hypoglycemia
- Severe Hypoglycemia
- Treating Mild and Moderate Hypoglycemia
- Treating Severe Hypoglycemia
- Specific Situations
2021-04-13
Resources
- Evaluation of the Risk of Cardio-Vascular Disease Tool - Patient Questionnaire
2021-04-11
Insulin - Classes
2021-03-28
Insulin
Digital Applications
- Since March 22nd the Freestyle®Libre 2 application is available on the App Store and the Google Play Store
Educational Videos
- Universi-D - YouTube Channel
- Update of the Nutrition section
2021-03-21
Resources
- Education - Low Blood Sugar-hypoglycemia (DQ)
- Education - High Blood Sugar-hyperglycemia (DQ)
- Sick Day Management - Urinary Tract Infections and Diabetes (DQ)
- Sick Day Management - Yeast Infections and Diabetes (DQ)
- Mental Health - Psychologists Quebec Association
- Mental Health - Quebec Association for Suicide Prevention
- Eye Care - Eye Health and Diabetes – Understanding Diabetic Retinopathy (DQ)
- Foot Care - Footcare and diabetes (DQ)
- Pregnancy - Gestational Diabetes (DQ)
- Pregnancy - Pregnancy and Type 1 Diabetes (DQ)
- Pregnancy - Pregnancy and Type 2 Diabetes (DQ)
- Smoking and Diabetes - Smoking and Diabetes (DQ)
- Smoking and Diabetes - J’ARRETE
- Diabetes Complications - Nerve Health and Diabetes – Understanding Diabetic Neuropathy (DQ)
- Diabetes Complications - Kidney Health and Diabetes – Understanding Diabetic Nephropathy (DQ)
- Diabetes Complications - Heart Health and Diabetes – Understanding Cardiovascular Diseases (DQ)
- Miscellaneous - Oral Health and Diabetes – Understanding Periodontal Disease (DQ)
- Miscellaneous - Checklist for a Person with Type 2 Diabetes (DQ)
Diabetes Québec
- Universi-D - Accredited On Line Training (SOFEDUC and OPQ) for HCP (FR only)
- Universi-D - Diabetes Update (7 Hours Training)
2021-03-20
Resources
- Diabetes Screening and Prevention - Understanding and preventing type 2 diabetes(DQ)
2021-03-19
Blood Glucose Monitoring
- Starting on March 22nd the Freestyle®Libre 2 will be available in pharmacies or on-line across the country
Classes
- Trulicity® - Instructions for Use - Video
2021-03-16
Renal Function
2021-03-15
Blood Glucose Monitoring
- Adding of the Freestyle®Libre 2 to the CGM and FGM comparison
2021-03-14
Lifestyle
- Nutrition - Snack and Diabetes (DQ)
- Nutrition - Symptoms and Treatment of Low Blood Sugar (DQ)
- Physical Activity- Get Fit at Home # 1 (DQ)
- Physical Activity-Get Fit at Home # 2 (DQ)
Blood Glucose Monitoring
- Blood Glucose Self-Monitoring Logbook (DQ)
- Freestyle LibreTM - Web Site
- OneTouch Verio ReflectTM
2021-03-13
Insulin
- Basaglar® - How to use the KwikPen®
- Toujeo® SoloSTAR® - Instructional Video
- Toujeo® DoubleSTAR® - Instructional Video
- Admelog® - Information Brochure
Classes
- Ozempic® - My Treatment Guide
2021-03-11
Insulin
- FlexTouch® (Novorapid®, Fisap®, Levemir® and Tresiba®) - Video demo. of the injection technic with the Flextouch Pen®
- Ozempic® - Video demo. of the injection technic
- Victoza® - Video demo. of the injection technic
- Tresiba® - Initiation, Titration and Technic Patient Handout
Lifestyle - Nutrition
2021-03-09
Classes
- Semaglutide Rybelsus®- Added 2 Educational Tools: Patient Guide and Getting Started
2021-03-08
Classes
- Empagliflozin Jardiance®- New Clinical Trial: EMPEROR Reduced (HF)
2021-03-04
Classes
- Linagliptin Trajenta® New monograph
Blood Glucose Monitoring
- Ascencia Contour® - Diabetes Care Tutoriels
2021-03-03
Classes
- Semaglutide Ozempic® add of Practical Tools for patients and HCP
Insulin
- Replacement of insuline lispro U100 (Humalog®) from Lilly to lispro U100 biosimilar (Admelog®) from Sanofi since march 3 2021 in Quebec (click on the link for more details)
Diabetes Québec
2021-02-25
Blood Glucose Monitoring
- Dexcom G6® - FAQ
Classes
- New clinical trial added for ar GLp-1 Trulicity: Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (Award 11)
2021-02-18
Blood Glucose Monitoring
- Dexcom G6® - New Links Clinical Evidence + Clinical Resources
- Dexcom G6® - New Order Form
Insulin
- Link Fixed : FIT Recommendations 4th ed.
2021-02-13
Blood Glucose Monitoring
- ACCU-CHEK® Roche Diabetes Care.
2021-02-03
Coverage
- The FreeStyle LibreTM Changes in eligibility and renewal criteria (see Coverage or Blood Glucose Monitoring tab)
- RAMQ Codes update (PDF)
2020-01-24
Educational Videos - Blood Glucose Monitoring
2020-12-31
Educational Videos
- Added a "Copy link" button. Allows you to copy the share link to the clipboard
Coverage
- RAMQ Codes update (PDF)
2020-12-02
Blood Glucose Monitoring
2020-11-16
Classes - Insulin
- Modifications to cost per molecule files:
- Classes (Steglatro discontinued + Invokamet very slight increase)
- Insulin (Adding Admelog)
2020-11-15
Educational Videos
2020-11-14
Blood Glucose Monitoring
- Freestyle LibreTM 3 new videos:
- Introducing the FreeStyle Libre System
- Difference between Interstitial Glucose and Blood Glucose
- Getting your first glucose reading by scanning your sensor
Insulin
- Add - Admelog®. See complete profile.
2020-11-13
Coverage
- RAMQ Codes update (PDF)
2020-01-11
Blood Glucose Monitoring
- Freestyle LibreTM Useful tips for sensor wear
2020-10-28
Blood Glucose Monitoring
- FreeStyle LibreTM - Remote Care 4 new links: You can do it remotely - Why prick, when you can scan*?- Patients can do it remotely - LibreView Support
2020-10-18
Classes - Insulin
2020-09-29
Insulin
- Update of : FIT Recommendations 4th ed.
Classes
- Forxiga : Addition of a clinical trial
2020-09-22
Diabetes Canada
- Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: Pharmacologic Glycemic Management of Type 2 Diabetes in Adults
2020-09-17
Classes
- Trulicity® - September 15 Health Canada gave a new indication for Trulicity: Indicated as an adjunct to diet, exercise, and standard of care therapy to reduce the risk of nonfatal stroke in adults with type 2 diabetes mellitus who have multiple cardiovascular risk factors or established cardiovascular disease.
2020-08-25
Homepage
- Tutorial video of the Diabetes Toolbox by the author
Classes + Insulin
2020-08-19
Insulin - Coverage
- Tresiba®, Lantus® (Vial 10 ml), BasaglarMC, ToujeoMC and Levemir® now covered by the Quebec Health Insurance Board (RAMQ) without exception. Novelties related to innovative medicines (fr)
Coverage
- RAMQ Codes update (PDF
2020-06-29
Lifestyle
- Nutrition - New link - Weight Management / Diabetes Canada
2020-05-24
Resources
- Injection Technic FIT Plus - Updating information
2020-04-29
Coverage
- RAMQ Codes update (PDF)
2020-04-26
Blood Glucose Monitoring - FreeStyle LibreTM
- Modification to the recognized indication for the payment of Freestyle LibreMC
2020-04-21
Diabetes Québec
Ressources
- Ramadan - Diabetes Canada Position Statement
2020-04-18
Educational Videos
- Add - How to use nasal glucagon BaqsimiTM.
2020-04-10
CLASSES - SGLT2 Inhibitors
- Forxiga® is now indicated as an adjunct to diet, exercise, and standard of care therapy to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and CV risk factors or established CV disease (see CLINICAL TRIALS).
2020-04-07
Renal Function
2020-04-04
CLASSES - GLP-1R
- Add - Semaglutide Rybelsus®. See complete profile.
2020-03-09
Digital Applications
- The Digital Applications tab is now online.
2020-03-04
Classes + Insulin
2020-03-01
Classes
- New indication for Invokana®. See product monograph
2020-02-09
Classes + Insulin
- Adding of clinical trials
2020-01-15
Videos / Visual Tools / Applications
- Adding a series of videos
2019-12-26
Consultant
- Jessie Haggai
Proprietary Pharmacist - Diabetes Educator
(see Contact us tab)
Ms. Haggai joins the team as a consultant.
2019-12-25
Classes + Insulin
- Add - Cost price per molecule - Classes - Insulin - Combined Files
2019-11-30
Coverage
- RAMQ Codes update (PDF)
2019-11-26
Classes + Insulin
- The product monograph is now available
2019-11-16
Video
- Modes of Action / Role of Insulin, DPP4-I/GLP-1 RA and SGLT2-I
2019-11-14
GLP-1RA / Coverage
- Semaglutide Ozempic® - Now exception drugs (RAMQ Form)
2019-11-10
Ressources
- Vaccination - Diabetes Canada
- Vaccination - Protocole d'immunisation du Québec (PIQ)
2019-11-03
Blood Glucose Monitoring
- Adding a printable blood glucose logbook
2019-10-27
Drug and Renal Function
- Update of the Renal Function Adjustment Chart
Blood Glucose Monitoring
- Freestyle LibreTM now working on Android
2019-10-10
Resources
- Ramadan - Diabetes Canada Position Statement
- Ramadan - Calendar
Education
- Nasal Glucagon BaqsimiTM - Health Canada Approval September 25 th
- Nasal Glucagon BaqsimiTM - Information
- Nasal Glucagon BaqsimiTM - Monograph
2019-10-03
Resources
- Cannabis - Diabetes Canada Position Statement
2019-09-15
Blood Glucose Monitoring
- Dexcom G6 disponible - Ressources and videos
- Freestyle LibreTM Videos/FAQ section
- Update of the Comparison Charts (PDF)
2019-09-02
Education / Hypoglycemia / Glucagon
2019-08-15
Coverage
- Glargine U300 Toujeo® now covered by the Quebec Health Insurance Board (RAMQ) according to certain criteria
2019-08-04
Blood Glucose Monitoring
- Update of the Intercative Guide
- Update of the Comparison Charts (PDF)
2019-07-19
Coverage
- The FreeStyle LibreTM glucose monitoring flash system is now covered by the Quebec Health Insurance Board (RAMQ) according to certain criteria (see Coverage or Blood Glucose Monitoring tab)
- RAMQ Codes update (PDF)
2019-06-20
GLP-1RA
- Semaglutide Ozempic®
New 4 mg flextouch maintenance pen. The 2 mg pen for the maintenance dose is no longer available
2019-05-31
Coverage
- RAMQ Codes update (PDF)
2019-04-30
Drug and Renal Function
- Update of the Renal Function Adjustment Chart
2019-04-11
Coverage
- RAMQ Codes update (PDF)
2019-03-20
Blood Glucose Monitoring
- New - Tab now completed
2019-03-07
Coverage
- RAMQ Codes update (PDF)
2019-02-01
Coverage
- RAMQ Codes update (PDF)
2018-12-19
Coverage
- RAMQ Codes update (PDF)
- SynjardyTM now code EN219
2018-11-23
Coverage
- RAMQ Codes update (PDF)
- Xigduo® and SynjardyTM now code EN150
2018-10-20
SGLT2
- Adding - Ertugliflozin SteglatroTM
- Adding - Ertugliflozin and Metformin SeglurometTM
- Adding - Ertugliflozin and Sitagliptin SteglujanTM
Drug and Renal Function
- New Chart Adjustment of the Medication with Renal Insufficiency
2018-10-01
Full update of the application
New
- Addition of a search function
- Overall improvement of performance and stability
- Available soon for all Canadian provinces (in English only)
2018-09-27
Coverage
- RAMQ Codes update (PDF) - Jardiance® now three codes EN148 - EN167 and EN179
- Xigduo® and SynjardyTM now code EN199
- Trajenta® now code EN148 and EN167
- Degludec U100 and U200 now exception drugs (form)
2018-06-23
GLP-1RA
- New document - Titration Protocol (Victoza® - Ozempic®- Trulicity® - AdlyxineTM)
2018-06-14
Drug and Renal Function
- Update of the Renal Function Adjustment Chart
2018-05-26
Coverage
- RAMQ Codes update (PDF) - Invokana® now three codes EN148, EN149 and EN167
2018-04-25
Lifestyle
- New document - Meal and Physical Activity Log (PDF)
Insulin
- New document - Basal Insulin Adjustments (PDF)
2018-04-15
Diabetes Canada
- New Diabetes Canadian Guidelines as April 9, 2018
Drug and Renal function
- New Chart Adjustment of the Medication with Renal Insufficiency
Classes
- New Vascular Protection Data for SGLT2 and GLP-1RA classes
Continuing Education
(DQ subsidiary)
Classes 
Insulin
Lifestyle
Blood Glucose Monitoring
Coverage
Diabetes Québec
Resources
Renal Function
Diabetes Canada
FAQ